RT Journal Article
T1 Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.
A1 Triguero, Ana
A1 Pedraza, Alexandra
A1 Pérez-Encinas, Manuel
A1 Mata-Vázquez, María Isabel
A1 Vélez, Patricia
A1 Fox, Laura
A1 Gómez-Calafat, Montse
A1 García-Delgado, Regina
A1 Gasior, Mercedes
A1 Ferrer-Marín, Francisca
A1 García-Gutiérrez, Valentín
A1 Angona, Anna
A1 Gómez-Casares, María Teresa
A1 Cuevas, Beatriz
A1 Martínez, Clara
A1 Pérez, Raúl
A1 Raya, José María
A1 Guerrero, Lucía
A1 Murillo, Ilda
A1 Bellosillo, Beatriz
A1 Hernández-Boluda, Juan Carlos
A1 Sanz, Cristina
A1 Álvarez-Larrán, Alberto
A1 On behalf  of the MPN Spanish Group (GEMFIN), 
K1 Low-risk
K1 Myelofibrosis
K1 Phlebotomies
K1 Polycythemia vera
K1 Thrombosis
AB Hematological control, incidence of complications, and need for cytoreduction were studied in 453 patients with low-risk polycythemia vera (PV) treated with phlebotomies alone. Median hematocrit value decreased from 54% at diagnosis to 45% at 12 months, and adequate hematocrit control over time ( 60 years, and microvascular symptoms constituted the main indications for starting cytoreduction. Median duration without initiating cytoreduction was significantly longer in patients younger than 50 years (
YR 2022
FD 2022-08-30
LK http://hdl.handle.net/10668/19719
UL http://hdl.handle.net/10668/19719
LA en
DS RISalud
RD Apr 19, 2025